TransMedics Historical Balance Sheet

TMDX Stock

USD 66.95 1.42 2.17%

Trend analysis of TransMedics Group balance sheet accounts such as Net Tangible Assets of 226.3 M, Accounts Payable of 15.4 M, Cash of 476.7 M or Other Assets of 748.6 K provides information on TransMedics' total assets, liabilities, and equity, which is the actual value of TransMedics Group to its prevalent stockholders. By breaking down trends over time using TransMedics balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining TransMedics Group latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether TransMedics Group is a good buy for the upcoming year.

TransMedics Inventory

53.41 Million

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

About TransMedics Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of TransMedics Group at a specified time, usually calculated after every quarter, six months, or one year. TransMedics Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of TransMedics and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which TransMedics currently owns. An asset can also be divided into two categories, current and non-current.

TransMedics Balance Sheet Chart

At this time, TransMedics' Total Current Assets are fairly stable compared to the past year. Property Plant Equipment is likely to rise to about 29.4 M in 2025, whereas Other Liabilities is likely to drop slightly above 901.6 K in 2025.

Total Assets Total Current Liabilities Other Liab Accounts Payable

Add Fundamental

Total Assets

Total assets refers to the total amount of TransMedics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in TransMedics Group books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on TransMedics balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of TransMedics Group are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Accounts Payable

An accounting item on the balance sheet that represents TransMedics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of TransMedics Group are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Most accounts from TransMedics' balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into TransMedics Group current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in TransMedics Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment.

	2022	2023	2024	2025 (projected)
Total Current Liabilities	23.7M	54.9M	63.2M	66.3M
Total Assets	277.1M	706.0M	812.0M	852.6M

Total Current Liabilities Total Assets

TransMedics balance sheet Correlations

	Total Assets	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Retained Earnings	Accounts Payable	Cash	Other Assets	Long Term Debt	Short Term Investments	Inventory	Total Liab	Total Current Assets	Common Stock	Property Plant Equipment	Other Current Liab	Net Receivables	Common Stock Shares Outstanding	Other Stockholder Equity	Short Long Term Debt Total	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Non Current Assets Total	Non Currrent Assets Other
Total Assets		0.99	0.74	0.01	0.82	-0.69	0.92	0.99	-0.13	0.99	-0.45	0.99	0.97	1.0	0.67	0.91	0.98	1.0	0.78	-0.09	0.99	0.99	0.98	0.76	0.99	-0.1
Total Current Liabilities	0.99		0.74	-0.05	0.81	-0.73	0.95	0.98	-0.09	0.98	-0.44	1.0	0.97	0.99	0.69	0.92	0.99	0.99	0.79	-0.05	0.98	0.98	0.97	0.77	0.98	-0.05
Total Stockholder Equity	0.74	0.74		-0.05	0.94	-0.76	0.58	0.73	0.03	0.66	-0.17	0.76	0.62	0.77	0.95	0.86	0.82	0.74	0.86	-0.23	0.67	0.66	0.61	0.33	0.65	-0.01
Other Liab	0.01	-0.05	-0.05		0.07	0.02	-0.21	0.02	-0.45	-0.04	0.1	-0.03	-0.07	0.02	0.0	0.09	-0.04	-0.01	0.3	0.34	-0.04	-0.02	-0.03	-0.2	-0.02	-0.35
Net Tangible Assets	0.82	0.81	0.94	0.07		-0.74	0.65	0.81	-0.28	0.74	-0.14	0.82	0.71	0.85	0.88	0.9	0.86	0.82	0.85	-0.2	0.75	0.75	0.7	0.41	0.74	-0.3
Retained Earnings	-0.69	-0.73	-0.76	0.02	-0.74		-0.66	-0.67	0.03	-0.62	0.04	-0.75	-0.62	-0.72	-0.81	-0.79	-0.76	-0.68	-0.78	0.01	-0.62	-0.61	-0.57	-0.32	-0.61	0.03
Accounts Payable	0.92	0.95	0.58	-0.21	0.65	-0.66		0.89	-0.05	0.94	-0.41	0.93	0.92	0.9	0.55	0.8	0.9	0.91	0.63	-0.14	0.94	0.94	0.93	0.83	0.94	-0.01
Cash	0.99	0.98	0.73	0.02	0.81	-0.67	0.89		-0.11	0.98	-0.55	0.98	0.96	0.99	0.66	0.93	0.97	1.0	0.78	-0.08	0.98	0.98	0.96	0.71	0.98	-0.05
Other Assets	-0.13	-0.09	0.03	-0.45	-0.28	0.03	-0.05	-0.11		-0.08	-0.28	-0.09	-0.1	-0.15	0.05	-0.12	-0.06	-0.11	-0.05	-0.04	-0.08	-0.1	-0.07	0.01	-0.09	0.98
Long Term Debt	0.99	0.98	0.66	-0.04	0.74	-0.62	0.94	0.98	-0.08		-0.48	0.98	0.98	0.98	0.6	0.85	0.96	0.98	0.72	-0.08	1.0	1.0	1.0	0.85	1.0	-0.04
Short Term Investments	-0.45	-0.44	-0.17	0.1	-0.14	0.04	-0.41	-0.55	-0.28	-0.48		-0.44	-0.51	-0.42	-0.1	-0.44	-0.41	-0.51	-0.25	-0.14	-0.49	-0.5	-0.5	-0.26	-0.5	-0.4
Inventory	0.99	1.0	0.76	-0.03	0.82	-0.75	0.93	0.98	-0.09	0.98	-0.44		0.97	0.99	0.71	0.93	0.99	0.99	0.8	-0.06	0.98	0.98	0.97	0.75	0.98	-0.05
Total Liab	0.97	0.97	0.62	-0.07	0.71	-0.62	0.92	0.96	-0.1	0.98	-0.51	0.97		0.95	0.57	0.84	0.95	0.96	0.7	0.07	0.98	0.98	0.98	0.83	0.98	-0.05
Total Current Assets	1.0	0.99	0.77	0.02	0.85	-0.72	0.9	0.99	-0.15	0.98	-0.42	0.99	0.95		0.7	0.93	0.98	0.99	0.8	-0.1	0.98	0.98	0.96	0.73	0.98	-0.12
Common Stock	0.67	0.69	0.95	0.0	0.88	-0.81	0.55	0.66	0.05	0.6	-0.1	0.71	0.57	0.7		0.81	0.77	0.67	0.91	-0.18	0.6	0.59	0.54	0.28	0.59	0.02
Property Plant Equipment	0.91	0.92	0.86	0.09	0.9	-0.79	0.8	0.93	-0.12	0.85	-0.44	0.93	0.84	0.93	0.81		0.94	0.92	0.88	-0.01	0.86	0.86	0.82	0.47	0.86	-0.08
Other Current Liab	0.98	0.99	0.82	-0.04	0.86	-0.76	0.9	0.97	-0.06	0.96	-0.41	0.99	0.95	0.98	0.77	0.94		0.97	0.84	-0.03	0.96	0.96	0.94	0.72	0.96	-0.03
Net Receivables	1.0	0.99	0.74	-0.01	0.82	-0.68	0.91	1.0	-0.11	0.98	-0.51	0.99	0.96	0.99	0.67	0.92	0.97		0.78	-0.1	0.99	0.99	0.97	0.74	0.98	-0.06
Common Stock Shares Outstanding	0.78	0.79	0.86	0.3	0.85	-0.78	0.63	0.78	-0.05	0.72	-0.25	0.8	0.7	0.8	0.91	0.88	0.84	0.78		0.05	0.73	0.73	0.69	0.4	0.72	-0.01
Other Stockholder Equity	-0.09	-0.05	-0.23	0.34	-0.2	0.01	-0.14	-0.08	-0.04	-0.08	-0.14	-0.06	0.07	-0.1	-0.18	-0.01	-0.03	-0.1	0.05		-0.08	-0.06	-0.05	-0.1	-0.06	0.05
Short Long Term Debt Total	0.99	0.98	0.67	-0.04	0.75	-0.62	0.94	0.98	-0.08	1.0	-0.49	0.98	0.98	0.98	0.6	0.86	0.96	0.99	0.73	-0.08		1.0	1.0	0.84	1.0	-0.04
Property Plant And Equipment Net	0.99	0.98	0.66	-0.02	0.75	-0.61	0.94	0.98	-0.1	1.0	-0.5	0.98	0.98	0.98	0.59	0.86	0.96	0.99	0.73	-0.06	1.0		1.0	0.83	1.0	-0.05
Current Deferred Revenue	0.98	0.97	0.61	-0.03	0.7	-0.57	0.93	0.96	-0.07	1.0	-0.5	0.97	0.98	0.96	0.54	0.82	0.94	0.97	0.69	-0.05	1.0	1.0		0.87	1.0	-0.02
Net Debt	0.76	0.77	0.33	-0.2	0.41	-0.32	0.83	0.71	0.01	0.85	-0.26	0.75	0.83	0.73	0.28	0.47	0.72	0.74	0.4	-0.1	0.84	0.83	0.87		0.84	0.03
Non Current Assets Total	0.99	0.98	0.65	-0.02	0.74	-0.61	0.94	0.98	-0.09	1.0	-0.5	0.98	0.98	0.98	0.59	0.86	0.96	0.98	0.72	-0.06	1.0	1.0	1.0	0.84		-0.04
Non Currrent Assets Other	-0.1	-0.05	-0.01	-0.35	-0.3	0.03	-0.01	-0.05	0.98	-0.04	-0.4	-0.05	-0.05	-0.12	0.02	-0.08	-0.03	-0.06	-0.01	0.05	-0.04	-0.05	-0.02	0.03	-0.04

Click cells to compare fundamentals

TransMedics Account Relationship Matchups

TransMedics balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	152.0M	134.9M	277.1M	706.0M	812.0M	852.6M
Total Current Liabilities	11.9M	23.2M	23.7M	54.9M	63.2M	66.3M
Total Stockholder Equity	103.9M	67.9M	187.4M	137.2M	157.8M	165.7M
Net Tangible Assets	54.6M	103.9M	67.9M	187.4M	215.5M	226.3M
Retained Earnings	(398.2M)	(442.4M)	(478.7M)	(503.7M)	(453.3M)	(476.0M)
Accounts Payable	1.2M	6.7M	3.3M	12.7M	14.6M	15.4M
Cash	24.6M	25.6M	201.2M	394.8M	454.0M	476.7M
Long Term Debt	34.7M	35.2M	58.7M	506.2M	582.1M	611.2M
Inventory	11.9M	14.9M	20.6M	44.2M	50.9M	53.4M
Total Liab	48.1M	67.0M	89.8M	568.8M	654.2M	686.9M
Total Current Assets	146.8M	118.7M	252.3M	510.7M	587.3M	616.6M
Common Stock	502.2M	510.5M	666.3M	641.1M	737.3M	375.9M
Property Plant Equipment	4.8M	4.8M	15.7M	24.4M	28.0M	29.4M
Other Current Liab	10.4M	16.3M	17.2M	38.2M	44.0M	46.2M
Net Receivables	6.9M	5.9M	27.6M	63.6M	73.1M	76.8M
Common Stock Shares Outstanding	24.7M	27.6M	29.6M	32.5M	37.4M	24.3M
Other Stockholder Equity	(105.3M)	(95K)	68.0M	(225K)	(202.5K)	(192.4K)
Short Long Term Debt Total	34.7M	43.8M	67.6M	515.9M	593.3M	623.0M
Property Plant And Equipment Net	4.8M	15.7M	24.4M	180.5M	207.6M	217.9M
Current Deferred Revenue	263K	250K	241K	2.0M	2.3M	2.4M
Net Debt	10.1M	(17.0M)	(133.6M)	121.1M	139.3M	146.3M
Non Current Assets Total	5.3M	16.2M	24.9M	195.4M	224.7M	235.9M
Cash And Short Term Investments	125.6M	92.5M	201.2M	394.8M	454.0M	476.7M
Common Stock Total Equity	331.2M	424.1M	502.2M	510.5M	587.1M	389.0M
Long Term Debt Total	33.7M	34.1M	34.7M	35.2M	40.5M	31.8M
Liabilities And Stockholders Equity	152.0M	134.9M	277.1M	706.0M	812.0M	852.6M
Non Current Liabilities Total	36.3M	43.8M	66.1M	513.9M	591.0M	620.5M
Other Current Assets	4.7M	5.5M	2.9M	8.0M	9.2M	9.7M
Net Invested Capital	138.5M	103.1M	246.1M	643.4M	739.9M	776.9M
Property Plant And Equipment Gross	4.8M	15.7M	24.4M	201.8M	232.0M	243.6M
Accumulated Other Comprehensive Income	(95K)	(188K)	(225K)	(199K)	(179.1K)	(188.1K)
Net Working Capital	134.9M	95.5M	228.6M	455.7M	524.1M	550.3M
Capital Stock	502.2M	510.5M	666.3M	641.1M	737.3M	563.8M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GM	General Motors
S	SentinelOne

Additional Tools for TransMedics Stock Analysis

When running TransMedics' price analysis, check to measure TransMedics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TransMedics is operating at the current time. Most of TransMedics' value examination focuses on studying past and present price action to predict the probability of TransMedics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TransMedics' price. Additionally, you may evaluate how the addition of TransMedics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

TransMedics Historical Balance Sheet

TransMedics Inventory

53.41 Million

About TransMedics Balance Sheet Analysis

TransMedics Balance Sheet Chart

Total Assets

Total Current Liabilities

Accounts Payable

TransMedics balance sheet Correlations

TransMedics Account Relationship Matchups

High Positive Relationship

High Negative Relationship

TransMedics balance sheet Accounts

Also Currently Popular

Additional Tools for TransMedics Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Net Receivables	+ 1.0	Total Assets
Inventory	+ 1.0	Total Current Liabilities
Net Receivables	+ 1.0	Cash
Short Long Term Debt Total	+ 1.0	Long Term Debt
Property Plant And Equipment Net	+ 1.0	Long Term Debt

Common Stock	- 0.81	Retained Earnings
Property Plant Equipment	- 0.79	Retained Earnings
Common Stock Shares Outstanding	- 0.78	Retained Earnings
Other Current Liab	- 0.76	Retained Earnings
Retained Earnings	- 0.76	Total Stockholder Equity
Inventory	- 0.75	Retained Earnings